Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alto Neuroscience Inc ANRO

Healthcare
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. Through insights derived from the Company’s scalable and proprietary Precision Psychiatry Platform, which applies rigorous data science and robust analytics to data gathered by... see more

Recent & Breaking News (NYSE:ANRO)

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Alto Neuroscience, Inc.'s Possible Securities Fraud

Accesswire November 10, 2024

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire November 9, 2024

The Schall Law Firm Invites Stockholders To Join An Inquiry Into Alto Neuroscience, Inc.'s Possible Securities Fraud

Accesswire November 8, 2024

Alto Neuroscience Inc May Have Defrauded Investors And Those With Losses Are Urged To Reach Out To The Schall Law Firm

Accesswire November 7, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alto Neuroscience, Inc. (ANRO) And Encourages Shareholders to Connect

Accesswire November 7, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Reach Out To The Schall Law Firm

Accesswire November 6, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Shareholders to Reach Out

Accesswire November 6, 2024

ANRO ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Alto Neuroscience, Inc. Investment

Accesswire November 6, 2024

The Schall Law Firm Invites Shareholders To Take Part In An Inquiry Into Alto Neuroscience, Inc. For Fraud

Accesswire November 5, 2024

Alto Neuroscience, Inc. (ANRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Accesswire November 5, 2024

Did Alto Neuroscience, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- ANRO

Accesswire November 5, 2024

ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm

Business Wire November 4, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire November 4, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alto Neuroscience, Inc. (ANRO) And Encourages Investors to Connect

Accesswire November 4, 2024

Alto Neuroscience to Participate in Upcoming Investor Conferences

Business Wire November 4, 2024

Alto Neuroscience, Inc. (ANRO) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Accesswire November 4, 2024

ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm

PR Newswire November 3, 2024

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire November 3, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Investors to Reach Out

Accesswire November 3, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire November 2, 2024